510(k) K233293
K233293 is an FDA 510(k) premarket notification submitted by Neurosigma, Inc. for the device "Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®". The FDA issued a decision of Substantially Equivalent on Jan 16, 2024. The device falls under product code QGL (Transcutaneous Nerve Stimulator For Adhd), a Class II device regulated under 21 CFR 882.5898. Neurosigma, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 16, 2024
- Date Received
- Sep 29, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Transcutaneous Nerve Stimulator For Adhd
- Device Class
- Class II
- Regulation Number
- 882.5898
- Review Panel
- NE
- Submission Type
- 510(k)
A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.
Need the full FDA record for Neurosigma, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.